Evidence is presented that has led us to abandon the hypothesis that receptor-mediated cyclic GMP formation in cultured nerve cells occurs via the influx of extracellular calcium ions and an increase in the cytosolic free calcium ion concentration. While the cyclic GMP response is absolutely dependent on the presence of Ca2 , there is no increase in free intracellular Ca2+ subsequent to agonist stimulation. Instead, we have found that muscarinic or histamine HI receptor stimulation elicits the release of arachidonic acid through a quinacrine-sensitive mechanism, possibly phospholipase A2. Inhibition of the release or metabolism of arachidonate by the lipoxygenase pathway prevents receptor-mediated cyclic GMP formation. We hypothesize that neurotransmitter receptors that mediate cyclic GMP synthesis function by releasing arachidonic acid and that an oxidative metabolite of arachidonic acid then stimulates soluble guanylate cyclase.
ABSTRACT
Evidence is presented that has led us to abandon the hypothesis that receptor-mediated cyclic GMP formation in cultured nerve cells occurs via the influx of extracellular calcium ions and an increase in the cytosolic free calcium ion concentration. While the cyclic GMP response is absolutely dependent on the presence of Ca2 , there is no increase in free intracellular Ca2+ subsequent to agonist stimulation. Instead, we have found that muscarinic or histamine HI receptor stimulation elicits the release of arachidonic acid through a quinacrine-sensitive mechanism, possibly phospholipase A2. Inhibition of the release or metabolism of arachidonate by the lipoxygenase pathway prevents receptor-mediated cyclic GMP formation. We hypothesize that neurotransmitter receptors that mediate cyclic GMP synthesis function by releasing arachidonic acid and that an oxidative metabolite of arachidonic acid then stimulates soluble guanylate cyclase.
Activation of certain classes of neurotransmitter receptors stimulates the synthesis of cyclic GMP within certain cells. In virtually every system studied, this cyclic GMP response is dependent on the presence of extracellular Ca2+ (1, 2) . Murine neuroblastoma clone NlE-115 cells possess muscarinic and histamine H1 receptors that mediate cyclic GMP formation (3) (4) (5) (6) . These cells, derived from a neuroblast, display many of the properties of normal differentiated neurons (7) and, as such, have proven to be an ideal model system for the study of the mechanisms of neurotransmitter interactions with nerve cells, including receptor activation, desensitization, and psychotherapeutic drug effects (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) .
Many of the same receptor types that elicit a cyclic GMP response also stimulate the turnover of inositides, including phosphatidylinositol (PtdIns), resulting in the formation of phosphatidic acid (PtdOH) via 1,2-diaclyglycerol (15) . Receptor-mediated Ptdlns turnover is hypothesized to cause an increase in the plasma membrane permeability to Ca2 , resulting in an increase in the intracellular free calcium ion concentration or [Ca2+]1 (15) . Muscarinic receptor stimulation of NlE-115 cells elicits a large increase in the incorporation of 32p into PtdIns (16) . Receptor-mediated phospholipid labeling or the "phosphatidylinositol effect" is well documented and occurs in response to numerous agonists in a variety of cellular and tissue preparations (15, 17 cyclic GMP formation appears to result from release of arachidonic acid by a quinacrine-sensitive mechanism with subsequent metabolism of arachidonic acid via the lipoxygenase pathway.
METHODS
Cell Culture Conditions. Murine neuroblastoma cells (clone NIE-115) were cultured in Dulbecco's modified Eagle's medium (GIBCO) without antibiotics and supplemented with 10% (vol/vol) newborn calf serum (GIBCO; medium I). Cells (passage number, <16) were grown in 20 ml of medium I in 75-cm2 Corning tissue culture flasks (250 ml; Corning) in an atmosphere of 10% C02/90% humidified air at 370C. Cells were subcultured by removing growth medium and incubating for 10 min in a modified Puck's D1 solution (ref 6; medium II) and resuspending in 10 ml of medium I.
The cells were then inoculated into flasks (4-8 x 105 per flask) on day 0. The culture medium was changed on days 4, 6, and on each day thereafter by adding 10 ml of fresh medium I and removing 10 ml of medium I. Cells were negative for mycoplasma by bacteriologic criteria.
Measurement of Relative Changes in Cyclic GMP Production. The details of the use of radioactively labeled precursor for measuring relative change in cyclic GMP formation in intact cells are described elsewhere (6) . In brief, the cells were harvested for assay by aspiration of medium I and incubation for 10 min in medium II, followed by isolation and low speed centrifugation (250 x g) for 90 sec at 50C. The pellet was washed twice with a phosphate-buffered sodium chloride solution (medium III) containing 110 mM NaCl/5.3 mM KCl/1.8 mM CaCl2/1.0 mM MgCl2/2.0 mM Na2HPO4/25 mM glucose/70 mM sucrose (adjusted to pH 7.3-7.4; osmolality, 335-340 mOsm). The cells were suspended by trituration in 2 ml of medium III, and 20 Al of this suspension was removed and used for enumeration of cells (Coulter Counter). Precursor labeling was achieved by adding [3H] In marked contrast to the time course of light emission from aequorin-loaded neuroblastoma cells (Fig. 1) is the time course of cyclic GMP formation stimulated by carbachol, histamine, ionophore X537A, and melittin (Fig. 2) Fig. 1 ), produced a relatively slow increase in cyclic GMP levels, which peaked only after more than 2 min (Fig. 2) platelets stimulated with thrombin, receptor-mediated PtdIns turnover and formation of diacylglycerol and PtdOH is followed by activation of phospholipase A2 and/or diglyceride lipase, which mediates the release of arachidonic acid from membrane lipids (22) (23) (24) (25) . We recently reported that athrombin stimulates cyclic GMP synthesis in neuroblastoma NiE-115 cells (26) . This cyclic GMP response requires catalytically active a-thrombin for maximal activity, and the concentration dependence in neuroblastoma cells and platelets is virtually identical. The cyclic GMP response of thrombin in NiE-115 cells is Ca2+ dependent, with nearly the same time course as that produced by carbachol or histamine, suggesting that neurotransmitter agonists may share with thrombin a common mechanism of action for stimulation of cyclic GMP formation.
Thrombin-stimulated arachidonic acid release in platelets is blocked by quinacrine and is reportedly due to phospholipase A2 inhibition (23, 27) . In our studies, quinacrine antagonized the cyclic GMP response in NlE-115 cells elicited by carbachol, histamine, and thrombin in a concentration-dependent manner (Table 1) with approximately equal potency against all three agonists. The IC50 (concentration that inhibits by 50%) values for quinacrine versus carbachol, histamine, and thrombin were 65, 102, and 90 AM, respectively. Quinacrine failed to inhibit sodium nitroprusside-induced cyclic GMP formation at concentrations as high as 750 ,M, far above those that markedly antagonized receptor-stimulated cyclic GMP formation, ruling out the possibility that quinacrine acts nonspecifically.
Finally, we obtained data that directly implicate the release of arachidonic acid in receptor-mediated cyclic GMP formation. Intact neuroblastoma cells were radiolabeled with [3H]arachidonic acid, which was quantitatively incorporated into phospholipids, and subsequently these cells were challenged with agonists and other agents (X537A and melittin) that cause cyclic GMP formation. Carbachol, histamine, X537A, and melittin increased [3H]arachidonic acid release under the same conditions in which these agonists cause cyclic GMP formation ( donate can undergo oxidative metabolism via cyclooxygenase or lipoxygenase and form prostaglandins or hydroxyicosatetraenoic acids, respectively. We examined the possible involvement of arachidonic acid metabolites in the cyclic GMP response produced by carbachol, histamine, and thrombin by using selective antagonists of cyclooxygenase and lipoxygenase. 5,8,11,14-Icosatetraynoic acid, a lipoxygenase inhibitor, produced a concentration-dependent blockade of carbachol-, histamine-, and thrombin-induced cyclic GMP formation ( Table 1 (Fig. 3 ). This scheme draws on some parallel observations made in other systems, most notably in platelets. In platelets stimulated with thrombin, the initial event is the activation of a phospholipase C, which stimulates Ptdlns turnover, resulting in the formation of PtdOH via 1,2-diacylglycerol (22) (23) (24) (25) . Muscarinic receptor stimulation greatly enhances Ptdlns turnover (increased by 680%) in murine neuroblastoma clone NlE-115 cells (16) . The formation of PtdOH in membrane phospholipids is hypothesized to be a calcium-gating mechanism (15, 29) , and increase in [Ca2+] , was thought to be the stimulus for guanylate cyclase activation (8) . In platelets, however, PtdIns breakdown is also associated with release of arachidonic acid by phospholipase A2 (22, 23) or by diglyceride lipase (24, 25) . We propose that an arachidonate release mechanism that operates in concert with the Ptdlns cycle such as occurs in platelets also underlies neuroblastoma receptormediated cyclic GMP responses. As we have shown, muscarinic and histaminergic stimulation of cells elicits [3H]arachidonic acid release, which is blocked by receptor antagonists (Table 2 ). These data demonstrate such an effect produced by carbachol or histamine. The stimulation of guanylate cyclase by arachidonic and other free fatty acids or by their oxidative derivatives and by hydroxyl radicals is well established in numerous experimental systems (1, (30) (31) (32) (33) (34) (35) , and the data presented here further implicate receptor-mediated re- (Fig. 2) Ca2+ -phospholipid complexes could act to effect conformational changes in membrane proteins, thus activating them. The hypothesis we favor for receptor-mediated slow neurotransmission (cyclic GMP formation) is that the agonist-receptor interaction causes local changes in the Ptdlns/PtdOH ratio as a result of phospholipase C action. Phospholipase A2 and/or diglyceride lipase may be Ca2+ accepting sites on the intracellular membrane surface because both are highly Ca2+-dependent and, as shown here, may be intricately involved in the mechanism of the neurotransmitter receptor-cyclic GMP transduction mechanism.
Within the scheme outlined in the present hypothesis, it is possible that calmodulin and/or the polyphosphoinositides are involved. Calmodulin regulates many Ca2+-dependent phenomena and has been found to stimulate phospholipase A2 in human platelets (37) and in renal medullary preparations (38) . In addition, more careful examination of PtdIns responses have revealed that phosphodiesteratic cleavage of polyphosphoinositides is the first response after receptor activation in numerous cellular and tissue preparations (17, 39) , including those of the central nervous system (40) . The possible involvement of these, as well as other Ca2+-dependent mechanisms in neurotransmitter-mediated cyclic GMP responses remains to be evaluated.
Other areas of particular interest are the nature of the arachidonate metabolites formed in response to neuronal receptor stimulation and the mechanism by which one or more of these activate guanylate cyclase or elicit other neuronal responses. Recently, it was shown that platelet guanylate cyclase is directly activated by arachidionic acid and linoleic acid that is released from the membranes (41) .
It has been previously hypothesized that because many of the same agonists that stimulate PtdIns turnover also cause cyclic GMP formation, the two events are interrelated (29, 42) . The major points that the present results add to the current knowledge of this phenomenon are as follows: (i) that a large calcium transient does not occur after receptor activation and (ii) that neurotransmitter receptor agonists that stimulate cyclic GMP formation also cause arachidonic acid release. Phospholipase A2 and diglyceride lipase are the two known enzymes that, when activated, cause arachidonic acid release. The fact that these enzymes are both stimulated by calcium may explain the Ca2+ dependency of receptormediated cyclic GMP formation in intact cells.
